Buy Needles And Syringes With No Prescription
M4B Store Banner
juicemasters
Riptropin Store banner
Generation X Bodybuilding Forum
Buy Needles And Syringes With No Prescription
Buy Needles And Syringes With No Prescription
Mysupps Store Banner
fitnespeptidestore
PM-Ace-Labs
Ganabol Store Banner
Spend $100 and get bonus needles free at sterile syringes
Professional Muscle Store open now
sunrise2
PHARMAHGH1
kinglab
ganabol2
Professional Muscle Store open now
over 5000 supplements on sale at professional muscle store
savage
granabolic1
napsgear-210x65
monster210x65
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
DeFiant
UGFREAK-banner-PM
STADAPM
yms-GIF-210x65-SB
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
wuhan2
dpharma
marathon-new-1
zzsttmy
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
azteca
advertise1x
ydv210x65
PCT-Banner-210x65
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store

Dat's - CJC-1295 & GHRP-6 (Basic Guides)

gyno; said:
Site reduction of adipose. Most say it is impossible (barring of course hormonal manipulation which may cause fat storage in particular areas). My question is two fold

1. Have you found any drug/supplement/procedure that would lead you to believe this may not be ture? I've noted from a recent post that you like to do things people say are impossible, so I wonder if you have experimented with this. If so, what were your results

2. I have a very strange thing going on in my body. I store fat first in my breast/chest area. I lose it last from there as well. Even when I KNOW that progesterone/estrogen is in check, I accumulate fat in that area first. Not only that, but in copious amounts. It's rather disturbing. I've even gone so far as to having it liposuctioned, and although it took much longer, upon gaining back some fat (going from a true 7% to around 11%) it returned to my chest first like it was a priority.:mad:.

This could be a big topic to explore and discuss. The answer is yes I have been interested in the possibility of using MT-II for spot reduction. It is demonstrated in mice and I put out a "feeler" here on this board on the topic of MT-II & weightloss. (weightloss unrelated to appetite decrease).

I didn't specifically post on spot reduction. Here is that thread: MTII - weightloss

I get interested in so many things that I can't keep track. Here were my thoughts at the time and perhaps it is directly relevant to you.

Brown Adipose Tissue -

From Wikipedia:

...more recently it has become clear that brown fat is not closely related to white fat, but to skeletal muscle, instead. Further, recent studies[3] using Positron Emission Tomography scanning of adult humans have shown that it is still present in adults in the upper chest and neck. The remaining deposits become more visible (increasing tracer uptake) with cold exposure, and less visible if an adrenergic beta blocker is given before the scan. The recent study could lead to a new method of weight loss, since brown fat takes calories from normal fat and burns it. Scientists were able to stimulate brown fat growth in mice, but human trials have not yet begun.​

Here is a little background science from Effects Of The Melanocortin Agonist Melanotan Ii, Central Pro-Opiomelanocortin And Interleukin-6 Gene Therapies On The Regulation Of Body Weight And Energy Homeostasis, Gang Li, A Dissertation Presented To The Graduate School Of The University Of Florida In Partial Fulfillment Of The Requirements For The Degree Of Doctor Of Philosophy University Of Florida 2003

Brown Adipose Tissue and Energy Expenditure

BAT is a specialized fat tissue in mammals heavily innervated by sympathetic nerves. The brown adipocytes contain abundant mitochondria with closely packed cristae that confer the characteristic brown color to this tissue. Thermogenesis in BAT is mainly mediated by norepinephrine activation of sympathetically innervated ß3 adrenoreceptors (Nedergaard et al., 2001). Energy expenditure through brown adipose tissue thermogenesis contributes either to maintenance of body temperature in a cold environment or to consumption of food energy, i.e. cold-induced or diet-induced thermogenesis. Both mechanisms involve a specific and unique protein: the uncoupling protein-1 (UCP1). UCP1, a 32-kDa protein, is exclusively expressed in mitochondria of brown adipocytes where it uncouples respiration from ATP synthesis and dissipates the proton gradient as heat (Nedergaard et al., 2001).

Skeletal Muscle and Energy Expenditure

Over much of the past century, the skeletal muscle, by virtue of its large size contributing 30–40% of body mass, has been considered the major tissue that enables mammals to adapt to changes in food availability. For example, the rate of heat production during periods of food scarcity is turned down in the skeletal muscle to conserve energy while it is geared up during food abundance to burn excess energy. However, the mechanisms by which skeletal muscle could allow such adaptations remain elusive. UCP3, a UCP1 homologue in muscle, has been proposed to participate in the regulation of thermogenesis and lipid metabolism (Wang et al., 2003). However, several recent studies cast doubt on its physiological relevance to muscle mitochondrial uncoupling (Hesselink et al., 2003; Cadenas et al., 1999; Iossa et al., 2001). Leptin has also been indicated to have direct thermogenic effects in skeletal muscle. Presumably, these effects require both the long form of leptin receptors and PI3K signaling (Dulloo et al., 2002). Muscle-type Carnitine palmitoyltransferase I (M-CPT I) is an important enzyme for energy homeostasis and fat metabolism by modulation of long-chain fatty acid (LCFA) entry into mitochondria, where the LCFAs undergo beta-oxidation (Jeukendrup, 2002). M-CPT I is located in the outer mitochondrial membrane and sensitive to inhibition by malonyl-CoA, which makes it an important site for metabolic regulation. Malony-CoA is the product of a reaction catalyzed by Acetyl-CoA carboxylase (ACC), the first step in fatty acid biogenesis from acetyl-CoA and preserved in nonlipogenic tissues such as skeletal muscles and heart muscle (Jeukendrup, 2002). The formation of malonyl-CoA may therefore offer a main control point of fatty acid catabolism through inhibition of CPT I in muscle.​

So is it Brown Fat that is a problem for you? I kinda doubt it. I believe the more brown fat you have in the chest area the easier it will be to lose fat there. When you diet down perhaps you are reducing brown fat and making it more difficult to reduce white fat. Perhaps tissue specific resistance to leptin is to blame for white fat accumulation... the tissue may have other signaling defects

Here is how administering MT-II worked in one study:

In lean rats, MTII prevented the decrease in brown adipose tissue UCP1, UCP2, and UCP3 expression and muscle UCP3 occurring during food restriction. In obese animals, MTII markedly increased brown adipose tissue (7-fold) and muscle (2.5-fold) UCP3 expression. The decrease in liver carnitine palmitoyltransferase-1 elicited by food restriction in lean and obese rats was prevented by MTII administration. In summary, the effects of MTII resemble those of leptin and are more marked in obese than in lean animals, in keeping with their reported reduced endogenous melanocortin tone. Melanocortin agonists may be useful in the treatment of obesity associated with impaired leptin signaling. - The Leptin-Like Effects Of 3-D Peripheral Administration Of A Melanocortin Agonist Are More Marked In Genetically Obese Zucker (Fa/Fa) Than In Lean Rats, Philippe Cettour-Rose And Franc¸ Oise Rohner-Jeanrenaud, Endocrinology 143: 2277–2283, 2002

Lots of things going on and I don't have a clear idea, just that MT-II may be effective at spot reduction in some spots for some people w/ certain specific characteristics/defects in signaling.
 
:) The wound healing is specific to IGF-1.

The two links I posted on the specific direct actions of GHRP on anti-catabolism & anabolism were actions/abilities of the GHRPs unrelated to GH release.

There are GHS-receptors (the receptors GHRPs bind to) in tissue other then the pituitary. These receptors in peripheral tissue (i.e. non-pituitary non-GH releasing cells) when bound to a GHRP ligand mediate specific events.

This is the reason Hexarelin was found to be beneficial to cardiac protection under certain negative cardiac events. There are other examples of the beneficial effects of GHRPs on specific tissue unrelated to GH release and I pointed to that as a potential adjunct therapy at site.

Growth Hormone is a longer term therapeutic tool. Its primary action is to increase IGF-1. It could be considered indirect since it instigates IGF-1 release.

However if you can not inject IGF-1 close to a wound (maybe the damage is internal) then you can not try to derive local benefit from an IGF-1 injection. Instead GH administration (or the GH releasing effects of GHRH/GHRP) will over time increase local (meaning in tissue) production and use of IGF-1.

All three actions are distinct and may have therapeutic utility.

DAT, in response to post #1213 where you state that IGF is the best wound healing growth factor, and that igf and ghrp should be injected as closely as possible to the injury, does this mean together or one or the other? I ask because i'm trying to understand the if the negative inhibitory effects of both igf and gh simultaneously adminastered as stated in post #161 is only the case if it is exogenous gh as opposed to an increase in natural gh. And If administering igf has a negative effect on my own gh secretion as stated in post #877, is the use of igf in wound healing simply a double edged sword, in which i need to choose my battles? Or can igf be used along side ghrp to stimulate my own production? I'm sorry if i have misunderstood your posts but please help me to understand how to use these effectively in injury rehab as it seems as though i read one post and then another which conflicts.

thanks DAT
 
the sexual side effects of MT2 make it wishy washy for me to attempt to use for fatloss :)
 
So when I am running a short 4 to 5 week cycle of igf should I use it either byitself or with ghrp near wound then resume Normal gh use?
 
Thank you Dat. More questions...less answers. LOL. Thats science in a nutshell. I'll be following along, if I have any epiphany's you will be the first to know.:p
 
Thank you Dat. More questions...less answers. LOL. Thats science in a nutshell. I'll be following along, if I have any epiphany's you will be the first to know.:p

Yes I know. But that can be a good thing, because you started with the premise that there is no such thing as spot reduction, and now we have moved toward a "maybe".

But lets say that MT-II is not really the answer... but what we are doing is looking for tissue specific changes in metabolism.

Here is another silly premise. "Fat cells don't die. They only shrink when you diet but multiply when you get fat." :rolleyes:

Some of what I do is push beyond the premise and discover it to be faulty.

Evidence of apoptosis in adipose tissue is accumulating. More work is needed to demonstrate the precise identity of the cells targeted, as well as to examine the situations during which apoptosis may occur in vivo. Our understanding of the molecular stimuli inducing apoptosis is also quite rudimentary at present, as is the possibility of regional anatomic site-specificity. Future work in this area is expected to dovetail with the emerging view of adipose tissue as a site of dynamic complexity, with sophisticated processes governing the interactions of preadipocytes and adipocytes. - Adipose cell apoptosis: death in the energy depot, A Sorisky, International Journal of Obesity (2000) 24, Suppl 4, S3-S7
 
Dat, in regards to above do you feel that there is anyway to impede or reduce the number of fat cells that are able to "regenerate" or be "reproduced" over the fat cells life cycle (life and death of fat cell)? I.E. allow less cells to be reproduced than the total number that have died.
 
yes, most certainly. Strangely enough, this is usually the thing that I enjoy most about science, the "hunt". Unfortunately, in this situation coming to the dead end that we often (more often than not) come to would be beyond dissapointing. Things change, patience diminishes, and hopelessness grows after years of dead ends when what you are persuing is near and dear to you (obviously due to vanity).
Yes I know. But that can be a good thing, because you started with the premise that there is no such thing as spot reduction, and now we have moved toward a "maybe".

But lets say that MT-II is not really the answer... but what we are doing is looking for tissue specific changes in metabolism.

Here is another silly premise. "Fat cells don't die. They only shrink when you diet but multiply when you get fat." :rolleyes:

Some of what I do is push beyond the premise and discover it to be faulty.

Evidence of apoptosis in adipose tissue is accumulating. More work is needed to demonstrate the precise identity of the cells targeted, as well as to examine the situations during which apoptosis may occur in vivo. Our understanding of the molecular stimuli inducing apoptosis is also quite rudimentary at present, as is the possibility of regional anatomic site-specificity. Future work in this area is expected to dovetail with the emerging view of adipose tissue as a site of dynamic complexity, with sophisticated processes governing the interactions of preadipocytes and adipocytes. - Adipose cell apoptosis: death in the energy depot, A Sorisky, International Journal of Obesity (2000) 24, Suppl 4, S3-S7
 
I'll keep this short and to the point.

Dat, Tesamorelin. Your opinions. What do you know about it?

I couldn't find anything in this thread.

Thanks lad.

Here is a link - http://www.medpagetoday.com/HIVAIDS/HIVAIDS/7581

Most of the current clinical trials of GHRH or GHRP are occurring with derivatives of either that were/are patentable derivatives of what we already have. They use code names & then the final drug name sometimes (such as Capromorelin).

Tesamorelin is sometimes referred to as a human growth hormone–releasing factor (GRF) but it isn't. GRF is the active portion or 29 amino acids of GHRH which is 44 amino acids.

Tesamorelin (code name TH9507) is just plain old GHRH(1-44) w/ one addition. A trans-3-hexenoyl group was added to the N-terminal to increase the half-life over that of native GHRH(1-44).

Now the group that was added overhangs and protects the GHRH's vulnerable bond between the 2nd & 3rd amino acid.

See below:

Clipboard01.jpg

That addition however makes it a moderate-lasting analog w/ GH releasing effects for up to 8 hours. The binding affinity is however identical to GHRH, just the the half-life is longer.


Anchoring rigid hydrophobic chains to stabilize growth hormone-releasing factor, Larocque A, Theratechnologies Inc. 2001
 

Cool find DR. Now with the elaboration made here you can see that pituitary concerns pretty much have only been expressed for longer-lasting analogs such as CJC-1295 (days) & Tesamorelin which lasts for 8 hours rather then those that just intitate single pulses like modified GRF(1-29) also referred to by some as CJC w/o the DAC.
 
Cool find DR. Now with the elaboration made here you can see that pituitary concerns pretty much have only been expressed for longer-lasting analogs such as CJC-1295 (days) & Tesamorelin which lasts for 8 hours rather then those that just intitate single pulses like modified GRF(1-29) also referred to by some as CJC w/o the DAC.

Thanks Dat.

Looks like Tesamorelin would be longer acting that GRF 1-29, but shorter acting than CJC-1295

We could list them up like this

Sermorelin - - GRF 1-29 - - Tesamorelin - - CJC-1295. Order from shortest acting to longest acting.

Ideally, we would like GRF 1-29, no?
 
yes, most certainly. Strangely enough, this is usually the thing that I enjoy most about science, the "hunt". Unfortunately, in this situation coming to the dead end that we often (more often than not) come to would be beyond dissapointing. Things change, patience diminishes, and hopelessness grows after years of dead ends when what you are persuing is near and dear to you (obviously due to vanity).

But since you need to make permanent alterations in the area's ability to proliferate fat cells because you have tried simply removing them, then any potential solution is "cutting edge".

I understand this is personal to your situation and you want a solution now. I know it sucks and scientific bullshit that doesn't give you an immediate solution is just in a way noise.

It doesn't really directly pertain to you but it reminds me of a Far Side cartoon.

What the owner says "Bad dog! You need to learn to behave yourself and be an obedient dog! Do not crap in the house...you are a very bad dog!

What the dog hears "blah blah Dog! blah blah blah blah blah blah Dog. blah blah blah Dog! :D

Come on bro smile. There are a lot of people in your situation, only they are seeking solutions to debilitating health problems. Eventually there will be a solution for you... but you can't wait for it to come to you and you can't give up now.
 
Thanks Dat.

Looks like Tesamorelin would be longer acting that GRF 1-29, but shorter acting than CJC-1295

We could list them up like this

Sermorelin - - GRF 1-29 - - Tesamorelin - - CJC-1295. Order from shortest acting to longest acting.

Ideally, we would like GRF 1-29, no?

Ideally GRF(1-29) modified by the 4 amino acid substitutions that allow it to survive quick enzymatic degradation and get the full benefit of a single pulse.

But what is truly ideal for pharmaceutical companies is a once a day pill.

One problem in the U.S. is that no company wants to combine a Ghrelin-mimetic & a GHRH analog. They experiment with one or the other over-looking the long-established synergy. In other countries drugs can be combined in a single pill but not in the U.S. especially if the drugs are owned by separate companies.
 
Hah, too true. Reality checks...we all need 'em...ruff
But since you need to make permanent alterations in the area's ability to proliferate fat cells because you have tried simply removing them, then any potential solution is "cutting edge".

I understand this is personal to your situation and you want a solution now. I know it sucks and scientific bullshit that doesn't give you an immediate solution is just in a way noise.

It doesn't really directly pertain to you but it reminds me of a Far Side cartoon.

What the owner says "Bad dog! You need to learn to behave yourself and be an obedient dog! Do not crap in the house...you are a very bad dog!

What the dog hears "blah blah Dog! blah blah blah blah blah blah Dog. blah blah blah Dog! :D

Come on bro smile. There are a lot of people in your situation, only they are seeking solutions to debilitating health problems. Eventually there will be a solution for you... but you can't wait for it to come to you and you can't give up now.
 
OK, I decided to do it!! I put on a pot of coffee and I'm going to read this book start to finish today!
 
Thanks Rooster. I found that, but since it was just a few sentences and such, I wanted to see if Dat would expand upon it.

But thank you for the help, I appreciate it. :)
No problem, I'm just excited that I finally learned how to use the search button myself...LOL
 
DAT-
This question is a little of topic so here goes:
I have allergies and have been told I have 3 times the histamine release than is normal.
Could an increase of HGH release via CJC-1295 W/O dac and ghrp-6 help this? Could the hyper histamine production be a symptom of some hormonal deficit?
Thank you.
 

Staff online

  • rAJJIN
    Moderator / FOUNDING Member

Forum statistics

Total page views
600,622,195
Threads
140,926
Messages
2,909,205
Members
162,798
Latest member
Harry Balzonya
NapsGear
HGH Power Store email banner
yourdailyvitamins
Prowrist straps store banner
yourrawmaterials
3
raws
Syntherol Site Enhancing Oil Synthol
aqpharma
yms-GIF-210x131-Banne-B
PM-Ace-Labs-bottom
ezgif-com-resize-2-1
MA Research Chem store banner
MA Supps Store Banner
volartek
Keytech banner
dp210-X131
Godbullraw-bottom-banner
Injection Instructions for beginners
finest-gears
PCT-Banner-210x131
FLASHING-BOTTOM-BANNER-210x131
Back
Top